Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
NDAE Exchange Introduces Mentor Program to Expand Peer-Led Learning Within NDAE Academy
-
The Mortgage Collaborative’s ‘The Sip’ Podcast Delivers Industry Insights and Peer Collaboration
-
Circle Pharma Receives FDA Orphan Drug Designation for CID-078 for the Treatment of Small Cell Lung Cancer
-
RYVYL Appoints Industry Veteran Brett Moyer to Its Board of Directors
-
NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6
-
Event hails Hongshan culture's 'brilliance'
-
Petri Plumbing, Heating, Cooling & Drain Cleaning makes it easier to go green at home
-
Salesfloor Joins Google Cloud Partner Advantage Program
-
DOUBLE GOOD CLIMBS TO NO. 13 ON CRAIN'S CHICAGO BUSINESS FAST 50 LIST
-
Vacation Mode: Harts Plumbers, Electricians and HVAC Technicians provide tips to keep home safe while owners are away
-
Exploring Mining Podcast featuring Trifecta Gold Ltd; Highlighting Yukon Exploration Strategy and Potential Gold Discoveries
-
Ocugen, Inc. Announces U.S. FDA Clearance of Investigational New Drug Amendment to Initiate Phase 2/3 Pivotal Confirmatory Clinical Trial of OCU410ST—Modifier Gene Therapy Candidate for Stargardt Di
-
CopperCorp Confirms Large Untested EM Anomaly Beneath Historical Cu-Au Mine at Jasper Hills, Tasmania
-
Neptune Engages ICP Securities Inc. for Automated Market Making Services
-
Elite Pharmaceuticals Reports Positive Results from a Pivotal Bioequivalence Study
-
Maritime Announces Completion of Share Consolidation
-
Canterra Minerals Identifies New District-Scale Gold Targets Along Valentine Lake Shear Zone Immediately Adjacent to Equinox Gold's Valentine Mine in Central Newfoundland
-
New Break Announces $895,000 Non-Brokered Private Placement Offering
-
Orestone Closes $600,000 Non-Brokered Private Placement and Shares-For-Debt Settlement; Crescat Capital LLC Becomes Strategic Shareholder
-
BLM Issues Final Environmental Impact Statement for Spring Valley
-
Awalé Extends Fremen Target Footprint by 5 km and Confirms New Gold Mineralization on its 100%-Owned Ground
-
New Holistic Book Reveals How Plants Speak and What They're Saying About Healing, Balance, and Connection
-
Mark Ford Joins Highway as Chief Capacity Officer
-
OTC Markets Group Welcomes Southpoint Bancshares Inc. to OTCQX
-
Jiangsu Hengrui Pharmaceuticals and Kailera Therapeutics Announce Clinical Data Presentations at the American Diabetes Association 85th Scientific Sessions
-
Supernus Pharmaceuticals to Acquire Sage Therapeutics, Strengthening its Neuropsychiatry Product Portfolio
-
Fury Finalizes Drill Targeting at its Newly Acquired Sakami Gold Project
-
Giyani Receives Letter of Interest from EXIM for US$225 million
-
Mirasol Signs MOU for the Sale of the Virginia Silver Project and Landholdings in Argentina for US$8 Million Plus 2% NSR Royalty
-
Guardian Capital Announces June 2025 Cash Distributions for Guardian Capital ETFs
-
Nobias Therapeutics Secures Preliminary FDA Alignment on Registrational Endpoints for NB-001 for Treatment of 22q11.2 Deletion Syndrome
-
Powerfleet Reports Annual FY2025 Results: A Breakout Year of Strategic Transformation and Scaled Growth
-
Grocery Dealz launches DFW Market with 'Thousand Dollars Worth of Free Groceries' Sweepstakes
-
Abcourt Intersects 4.1 g/t Gold over 11 Metres in Channel on the Former Cambior Stripping, extends the mineralized zone over a length of now 300m in the Cartwright Area of the Flordin Project, and Pre
-
Eolo Pharma Publishes First-in-Human Study in Nature Metabolism on Novel Obesity Drug Activating Energy-Burning Pathway
-
Anfield Files Notice of Intent to Conduct Drill Program As It Expands Its Hub-And-Spoke Uranium and Vanadium Production Model
-
VivoPower Advances US$308 Million Direct NASDAQ Spin-Off of Caret Digital
-
NLS Pharmaceutics CEO Issues Letter to Shareholders
-
NUZ-001 Shows Promise in Zebrafish Model of Huntington's Disease
-
Taoping Regains Compliance with Nasdaq Minimum Bid Price Requirement
-
Tonix Pharmaceuticals Presented Data and Analyses of TNX-102 SL Treatment Effects on Fibromyalgia at the Annual European Congress of Rheumatology (EULAR) 2025
-
PATHOLOGICAL COMPLETE RESPONSE RECORDED IN PATIENT FROM ACCENT CANCER TRIAL
-
Quest Analytics Announces Strategic Integration Partnership with Arcadia
-
Treetoscope and Nutrien Team Up to Transform Irrigation Efficiency Across the Americas
-
Chicago Atlantic Real Estate Finance Declares Common Stock Dividend of $0.47 for the Second Quarter of 2025
-
CHERYL HINES' TRAILER PROWLING TO SARDINIA
-
Graphite One Enters FAST-41 60-Day Planning and Timetable Period
-
Ocular Therapeutix™ to Participate in Clinical Trials at the Summit (CTS) 2025
-
Toyota Prius Plug-in Hybrid Gets Edgier with New Nightshade Edition
-
EyePoint Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
